The intent of this policy brief is to present the adoption history and regulatory challenges that developing countries have experienced such that aspiring countries might find helpful guidance to make informed decisions on their GM crop biosafety regulatory approach. The brief argues that overly restrictive regulations failed to result in the desired policy outcome when economic stakes were too appealing for farmers to forgo adoption. The brief concludes with regulatory policy implication for African countries.